Management of inter-episodic periods in patients with bipolar disorder

References

• Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241–251.
   PubMed Web of Science ®Google Scholar
• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. The Lancet. 2015;387:1561–1572.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. The global burden of disease: 2004 update. Geneva: WHO press; 2008.
   Google Scholar
• Angst F, Stassen HH, Clayton PJ, et al. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68:167–181.
   PubMed Web of Science ®Google Scholar
• Licht RW, Vestergaard P, Brodersen A. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up. Bipolar Disord. 2008;10:79–86.
   PubMed Web of Science ®Google Scholar
• De Dios C, Ezquiaga E, Agud JL, et al. Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients. J Affect Disord. 2012;143:160–165.
   PubMed Web of Science ®Google Scholar
• Judd LL, Schettler PJ, Akiskal HS, et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry. 2008;65:386–394.
   PubMed Web of Science ®Google Scholar
• Frye MA, Yatham LN, Calabrese JR, et al. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J Clin Psychiatry. 2006;67:1721–1728.
   PubMed Web of Science ®Google Scholar
• Soreca I, Frank E, Kupfer DJ. The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? Depress Anxiety. 2009;26(1):73–82.
   PubMed Web of Science ®Google Scholar
• Sanchez-Moreno J, Martinez-Aran A, Tabares-Seisdedos R, et al. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom. 2009;78:285–297.
   PubMed Web of Science ®Google Scholar
• Sole B, Bonnin CM, Torrent C, et al. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr Scand. 2012;125:309–317.
   PubMed Web of Science ®Google Scholar
• Bonnin CM, Martinez-Aran A, Torrent C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121:156–160.
   PubMed Web of Science ®Google Scholar
• Samalin L, Llorca PM, Giordana B, et al. Residual symptoms and functional performance in a large sample of euthymic bipolar patients in France (the OPTHYMUM study). J Affect Disord. 2014;159:94–102.
   PubMed Web of Science ®Google Scholar
• Samalin L, De Chazeron I, Vieta E, et al. Residual symptoms and specific functional impairments in euthymic patients with bipolar disorder. Bipolar Disord. 2016;18:164–173.
   PubMed Web of Science ®Google Scholar
• MacQueen GM, Young LT, Joffe RT. A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatr Scand. 2001;103:163–170.
   PubMed Web of Science ®Google Scholar
• Kessing LV. Recurrence in affective disorders. Br J Psychiatry. 1998;172:23–28.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne PP, Post RM, Uhde TW, et al. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl. 1985;317:1–34.
   PubMedGoogle Scholar
• Samalin L, Reinares M, De Chazeron I, et al. Course of residual symptoms according to the duration of euthymia in remitted bipolar patients. Acta Psychiatr Scand. 2016. [ cited 2016 Mar 30]. doi:10.1111/acps.12568.
   PubMedGoogle Scholar
• Dennehy EB, Suppes T, Rush AJ, et al. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the texas medication algorithm project. Psychol Med. 2005;35:1695–1706.
   PubMed Web of Science ®Google Scholar
• Perlis RH. Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians. Curr Med Res Opin. 2007;23:467–475.
   PubMed Web of Science ®Google Scholar
• Samalin L, Guillaume S, Auclair C, et al. Adherence to guidelines by French psychiatrists in their real world of clinical practice. J Nerv Ment Dis. 2011;199(4):239–243.
   PubMed Web of Science ®Google Scholar
• Frank E, Prien RF, Jarrett JB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48:851–855.
   PubMed Web of Science ®Google Scholar
• Tohen M, Frank E, Bowden CL, et al. The International Society for bipolar disorders (ISBD) task force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009;11(5):453–473.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016. [ cited 2016 Mar 15]. doi:10.1177/0269881116636545.
   Google Scholar
• National Institute for Health and Care Excellence. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents in primary and secondary care (Clinical Guideline 185); 2014; [ cited 2016 Feb 02]. Available from: www.nice.org.uk/guidance/cg185
   Google Scholar
• Management of Bipolar Disorder in Adults. Malaysia Health Technology Assessment Section (MaHTAS). Ministry of Health Malaysia, Putrajaya, Malaysia; 2014; [ cited 2016 Feb 02]. Available from: www.moh.gov.my/English.php/pages/view/217
   Google Scholar
• Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15(1):1–44.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, O’Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(Suppl 3):5–69.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49(12):1087–1206.
   PubMed Web of Science ®Google Scholar
• Bravo MF, Lahera G, Lalucat L, et al. Clinical practice guideline on bipolar disorder: drug and psychosocial therapy. Asociación Española de Neuropsiquiatría. Med Clin (Barc). 2013;141(7):305.e1-e10.
   PubMedGoogle Scholar
• Guía de Práctica Clínica sobre Trastorno Bipolar. Ministerio de Sanidad, Servicios Sociales e Igualdad, Universidad de Alcalá. Madrid, Asociación Española de Neuropsiquiatría; 2005; [ cited 2016 Feb 02]. Available from:www.guiasalud.es/GPC/GPC_510_Trastorno_Bipolar_compl.pdf
   Google Scholar
• Samalin L, Guillaume S, Courtet P, et al. French Society for Biological Psychiatry and Neuropsychopharmacology task force. Formal consensus for the treatment of bipolar disorder: an update (2014). Encephale. 2015;41(1):93–102.
   PubMed Web of Science ®Google Scholar
• Llorca PM, Courtet P, Martin P, et al. Screening and management of bipolar disorders: results. Encephale. 2010;36(Suppl 4):S86–102.
   PubMedGoogle Scholar
• Llorca PM, Courtet P, Martin P, et al. Screening and management of bipolar disorders: methodology. Encephale. 2010;36(Suppl 4):S79–85.
   Google Scholar
• Post RM, Leverich GS, Kupka RW, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71:864–872.
   PubMed Web of Science ®Google Scholar
• De Dios C, González-Pinto A, Montes JM, et al. Predictors of recurrence in bipolar disorders in Spain (PREBIS study data). J Affect Disord. 2012;141(2–3):406–414.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Andersen PK. Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders. Curr Psychiatry Rep. 2005;7(6):413–420.
   PubMedGoogle Scholar
• Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13:87–98.
   PubMed Web of Science ®Google Scholar
• López-Jaramillo C, Lopera-Vásquez J, Gallo A, et al. Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord. 2010;12(5):557–567.
   PubMed Web of Science ®Google Scholar
• Berk M, Hallam K, Malhi GS, et al. Evidence and implications for early intervention in bipolar disorder. J Ment Health. 2010;19(2):113–126.
   PubMed Web of Science ®Google Scholar
• Magalhaes PV, Dodd S, Nierenberg AA, et al. Cumulative morbidity and prognostic staging of illness in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Aust N Z J Psychiatry. 2012;46:1058–1067.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry. 2000;57:481–489.
   PubMed Web of Science ®Google Scholar
• Murru A, Colom F, Nivoli A, et al. When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations. Eur Psychiatry. 2011;26(3):183–186.
   PubMed Web of Science ®Google Scholar
• Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010;375(9712):385–395.
   PubMed Web of Science ®Google Scholar
• Murru A, Popovic D, Pacchiarotti I, et al. Management of adverse effects of mood stabilizers. Curr Psychiatry Rep. 2015;17(8):603.
   PubMed Web of Science ®Google Scholar
• Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 2010;12(1):1–9.
   PubMed Web of Science ®Google Scholar
• Pompili M, Gonda X, Serafini G, et al. Epidemiology of suicide in bipolar disorders: a systematic review of the literature. Bipolar Disord. 2013;15(5):457–490.
   PubMed Web of Science ®Google Scholar
• Pacchiarotti I, Bond DJ, Baldessarini RJ, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013;170(11):1249–1262.
   PubMed Web of Science ®Google Scholar
• Petrides G, Tobias KG, Kellner CH, et al. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology. 2011;64:129–140.
   PubMed Web of Science ®Google Scholar
• Reinares M, Sánchez-Moreno J, Fountoulakis KN. Psychosocial interventions in bipolar disorder: what, for whom, and when. J Affect Disord. 2014;156:46–55.
   PubMed Web of Science ®Google Scholar
• Lam DH, Jones SH, Hayward P. Cognitive therapy for bipolar disorder: a therapist’s guide to concepts, methods and practice. Hoboken, NJ: John Wiley & Sons; 2010.
   Google Scholar
• Colom F, Vieta E. Psychoeducation manual for bipolar disorder. Cambridge: Cambridge University Press; 2006.
   Google Scholar
• Miklowitz DJ. Bipolar disorder: a family-focused treatment approach. New York, NY: Guilford Press; 2008.
   Google Scholar
• Frank E. Treating bipolar disorder: a clinician’s guide to interpersonal and social rhythm therapy. New York, NY: Guilford Press; 2005.
   Google Scholar
• Torrent C, Bonnin Cdel M, Martínez-Arán A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry. 2013;170(8):852–859.
   PubMed Web of Science ®Google Scholar
• Ng F, Mammen OK, Wilting I, et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11(6):559–595.
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T. Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord. 2008;10:163–178.
   PubMed Web of Science ®Google Scholar
• Schneck C, Miklowitz D, Calabrese J, et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the systematic treatment enhancement program. Am J Psychiatry. 2004;161:1902–1908.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Schaffer A, Beaulieu S. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid conditions. Ann Clin Psychiatry. 2012;24(1):2–3.
   PubMed Web of Science ®Google Scholar
• Schaffer A, McIntosh D, Goldstein BI, et al. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry. 2012;24(1):6–22.
   PubMed Web of Science ®Google Scholar
• Beaulieu S, Saury S, Sareen J, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry. 2012;24(1):38–55.
   PubMed Web of Science ®Google Scholar
• Weiss RD, Griffin ML, Kolodziej ME, et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry. 2007;164:100–107.
   PubMed Web of Science ®Google Scholar
• Samalin L, Tremey A, Llorca P-M. Quetiapine extended release for the treatment of bipolar disorder. Expert Rev Neurother. 2014;14(9):987–1005.
   PubMed Web of Science ®Google Scholar
• Young AH, McElroy SL, Olausson B, et al. A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder. World J Biol Psychiatry. 2014;15(2):96–112.
   PubMed Web of Science ®Google Scholar
• Weisler RH, Nolen WA, Neijber A, et al. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). J Clin Psychiatry. 2011;72(11):1452–1464.
   PubMed Web of Science ®Google Scholar
• Suppes T, Vieta E, Liu S, et al. Maintenance treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with lithium or divalproex (trial 127). Am J Psychiatry. 2009;166(4):476–488.
   PubMed Web of Science ®Google Scholar
• Vieta E, Suppes T, Eggens I, et al. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord. 2008;109(3):251–263.
   PubMed Web of Science ®Google Scholar
• Popovic D, Reinares M, Goikolea JM, et al. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. Eur Neuropsychopharmacol. 2012;22(5):339–346.
   PubMed Web of Science ®Google Scholar
• Popovic D, Torrent C, Goikolea JM, et al. Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study. Acta Psychiatr Scand. 2014;129(5):366–374.
   PubMed Web of Science ®Google Scholar
• Amsterdam JD, Lorenzo-Luaces L, Soeller I, et al. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study. J Affect Disord. 2015;185:31–37.
   PubMed Web of Science ®Google Scholar
• Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry. 2010;167(7):792–800.
   PubMed Web of Science ®Google Scholar
• Popovic D, Reinares M, Scott J, et al. Polarity index of psychological interventions in maintenance treatment of bipolar disorder. Psychother Psychosom. 2013;82(5):292–298.
   PubMed Web of Science ®Google Scholar
• Vieta E. Staging and psychosocial early intervention in bipolar disorder. Lancet Psychiatry. 2015;2:483–485.
   PubMed Web of Science ®Google Scholar
• Frank E, Nimgaonkar VL, Phillips ML, et al. All the world’s a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry. 2015;20(1):23–31.
   PubMed Web of Science ®Google Scholar
• Grande I, Magalhães PV, Chendo I, et al. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand. 2014;129(6):437–444.
   PubMed Web of Science ®Google Scholar
• Kapczinski F, Magalhaes PV, Balzanza-Martinez V, et al. Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force report. Acta Psychiatr Scand. 2014;130:354–363.
   PubMed Web of Science ®Google Scholar
• Garay RP, Llorca PM, Young AH, et al. Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment. Drug Discov Today. 2014;19(11):1792–1800.
   PubMed Web of Science ®Google Scholar
• O’Brien PL, Thomas CP, Hodgkin D, et al. The Diminished Pipeline for Medications to Treat Mental Health and Substance Use Disorders. Psychiatr Serv. 2014;65(12):1433–1438.
   PubMed Web of Science ®Google Scholar
• Vieta E, Torrent C, Martinez-Aran A. Functional remediation for bipolar disorder. Cambridge: Cambridge University Press; 2014.
   Google Scholar